GARCEAU ROGER has filed 4 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 24000 shares of Protara Therapeutics, Inc. ($PRTO) on June 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Protara Therapeutics, Inc. | $PRTO | GARCEAU ROGER | Not found | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 40,707,937 | 9999.99% | 0.06% |
| June 7, 2024 | Protara Therapeutics, Inc. | $PRTO | GARCEAU ROGER | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 11,420,948 | 9999.99% | 0.09% |
| Jan. 1, 2024 | Entera Bio Ltd. | $ENTX | GARCEAU ROGER | Director | A | Stock Option (right to buy) | 108333 | $0.00 | 108,333.0000 | 29,007,794 | 9999.99% | 0.37% |
| Jan. 2, 2023 | Entera Bio Ltd. | $ENTX | GARCEAU ROGER | Director | A | Stock Option (right to buy) | 89041 | $0.00 | 89,041.0000 | 0 | 9999.99% | 0.00% |